TXNIP Regulates Peripheral Glucose Metabolism in Humans
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Type 2 diabetes mellitus (T2DM) is characterized by defects in insulin secretion and action. Impaired glucose uptake in skeletal muscle is believed to be one of the earliest features in the natural history of T2DM, although underlying mechanisms remain obscure. METHODS AND FINDINGS: We combined human insulin/glucose clamp physiological studies with genome-wide expression profiling to identify thioredoxin interacting protein (TXNIP) as a gene whose expression is powerfully suppressed by insulin yet stimulated by glucose. In healthy individuals, its expression was inversely correlated to total body measures of glucose uptake. Forced expression of TXNIP in cultured adipocytes significantly reduced glucose uptake, while silencing with RNA interference in adipocytes and in skeletal muscle enhanced glucose uptake, confirming that the gene product is also a regulator of glucose uptake. TXNIP expression is consistently elevated in the muscle of prediabetics and diabetics, although in a panel of 4,450 Scandinavian individuals, we found no evidence for association between common genetic variation in the TXNIP gene and T2DM. CONCLUSIONS: TXNIP regulates both insulin-dependent and insulin-independent pathways of glucose uptake in human skeletal muscle. Combined with recent studies that have implicated TXNIP in pancreatic beta-cell glucose toxicity, our data suggest that TXNIP might play a key role in defective glucose homeostasis preceding overt T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 TXNIP Expression in Individuals with Diabetes or at Risk for Developing Diabetes (A) TXNIP expression levels from individuals with NGT, IGT, or T2DM, using data from our previously published microarray study [18]. * p < 0.02; ** p < 0.01, Mann-Whitney U-test. (B) TXNIP expression levels from NGT individuals with family history of T2DM (FH+) or without (FH−), as well as individuals with T2DM, using data from a previously published microarray study [27]. * p < 0.03, Mann-Whitney U-test.](https://figures.cochat.ai/paper-figures/ca9ef16bc19d42259bbcc36f2b7c4340/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-2.jpg)

![Figure 4 Insulin-Mediated Glucose Uptake Versus TXNIP Expression This relationship is shown for individuals with NGT, IGT, and T2DM. Linear regression parameters are indicated for each of the groups. Data are from our previously published microarray study [18].](https://figures.cochat.ai/paper-figures/c969253506d74789b5b972b212cc68b2/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-4.jpg)

![Figure 6 Pattern of Genetic Variation at the TXNIP Locus Linkage disequilibrium between SNPs was analyzed using Haploview [55], and D′ values were calculated with 95% confidence intervals. D′ plot for each square depicts the magnitude of linkage disequilibrium for a pair of markers, red indicates high D′ with high logarithm of odds (LOD) score, while white indicates low D′ with low LOD score, and blue indicates high D′ with low LOD score.](https://figures.cochat.ai/paper-figures/1e45333953bb4d3999d14146d7c357ce/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-6.jpg)
![Figure 7 Model of TXNIP Regulation and Action and Its Potential Role in the Pathogenesis of T2DM (A) Previous studies have shown that glucose induces the expression of TXNIP in a variety of cells and tissues. In this study we show that insulin suppresses the expression of TXNIP. Moreover, we have found that forced expression of TXNIP results in reduced glucose uptake, while inhibition of TXNIP enhances glucose uptake. These results suggest that TXNIP serves as a glucose- and insulin-sensitive homeostatic switch that regulates glucose uptake in the periphery. (B) Role of TXNIP in glucose toxicity in the β-cell and in impaired glucose uptake in the periphery. Insulin deficiency or hyperglycemia can increase TXNIP levels in muscle, resulting in impaired peripheral glucose uptake. The pancreatic β-cell is initially able to compensate by secreting more insulin, but eventually the β-cell compensation fails. The resulting hyperglycemia may then elevate pancreatic β-cell TXNIP expression, which can induce apoptosis [40]. The loss of β-cells, in turn, results in decreased insulin production that further exacerbates peripheral IGT. The vicious cycle would eventually spiral to T2DM.](https://figures.cochat.ai/paper-figures/00021f5e308f4c0db15afac10c663543/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“TXNIP not only binds to and inhibits thioredoxin, but also antagonizes glucose uptake through a yet undefined mechanism (Parikh et al., 2007).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Parikh et al., 2007
In the citing paper
“TXNIP not only binds to and inhibits thioredoxin, but also antagonizes glucose uptake through a yet undefined mechanism (Parikh et al., 2007).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Parikh et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426 · cited 1×
“RNA Isolation, Target Preparation, and Hybridization RNA from skeletal muscle biopsies for studies A and B were extracted by the guadinium thiocyanate method [11].”
MethodHaploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525 · cited 1×
“Linkage disequilibrium between SNPs was analyzed using Haploview [55], and D9 values were calculated with 95% confidence intervals.”
MethodGolub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516 · cited 1×
“For study A, targets from human skeletal muscle biopsies [12] were hybridized to the Affymetrix HG-U133A GeneChip (http://www.”
MethodIn silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationBiochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764 · cited 1×
“To relate expression data with insulin-stimulated glucose uptake, a GEE model was used to adjust for the interdependence between twins [9,30].”
MethodBase-Calling of Automated Sequencer Traces Using Phred. I. Accuracy Assessment
Ewing, B., Hillier, L., Wendl, M. C., & Green, P. (1998) · Genome Research · doi:10.1101/gr.8.3.175 · Cited by 6,967 · cited 1×
“Each base was called using the PHRED software package [19,20], and quality scores were assigned.”
MethodBase-Calling of Automated Sequencer Traces Using Phred. II. Error Probabilities
Ewing, B., & Green, P. (1998) · Genome Research · doi:10.1101/gr.8.3.186 · Cited by 5,439 · cited 1×
“]. Genomic DNA was isolated from peripheral blood using standard procedures. We used specific primers (Applied Biosystems) to amplify the region by PCR. Sequencing was performed using Big Dye version 3.1 Cycle Sequencing kit (Applied Biosystems) according to the manufacturer's instructions, and separation was done on…”
MethodInfluential
Research works printed but not linked: 56
- Kahn, 1994, Diabetes, 43, 1066
- Eriksson, 1989, N Engl J Med, 321, 337
- Lyssenko, 2005, Diabetes, 54, 166
- Martin, 1992, Lancet, 340, 925
- Groop, 1996, Diabetes, 45, 1585
- Roden, 2005, Int J Obes, 2, S111
- Shulman, 2000, J Clin Invest, 106, 171
- Eriksson, 1990, Diabetologia, 33, 526
- Ling, 2004, J Clin Invest, 114, 1518
- Poulsen, 2005, Diabetes, 54, 275
- Chomczynski, 1987, Anal Biochem, 162, 156
- Golub, 1999, Science, 286, 531
- Wabitsch, 2001, Int J Obes Relat Metab Disord, 25, 8
- Al-Khalili, 2003, Cell Mol Life Sci, 60, 991
- Rubin, 1977, J Biol Chem, 252, 3554
- Al-Khalili, 2003, Biochem Biophys Res Commun, 307, 127
- Yoshioka, 2004, Circulation, 109, 2581
- Mootha, 2003, Nat Genet, 34, 267
- Ewing, 1998, Genome Res, 8, 186
- Ewing, 1998, Genome Res, 8, 175
- Staden, 1996, Mol Biotechnol, 5, 233
- de Bakker, 2005, Nat Genet, 37, 1217
- Florez, 2004, Diabetes, 53, 3313
- Purcell, 2003, Bioinformatics, 19, 149
- McClintick, 2006, BMC Bioinformatics, 7, 49
- Tusher, 2001, Proc Natl Acad Sci U S A, 98, 5116
- Patti, 2003, Proc Natl Acad Sci U S A, 100, 8466
- Yechoor, 2002, Proc Natl Acad Sci U S A, 99, 10587
- Yechoor, 2004, Proc Natl Acad Sci U S A, 101, 16525
- Zeger, 1986, Biometrics, 42, 121
- Zandbergen, 2005, Biochem J, 392, 313
- Phan, 2004, Nature, 432, 635
- Lee, 2003, Science, 302, 453
- Nishiyama, 1999, J Biol Chem, 274, 21645
- Shalev, 2002, Endocrinology, 143, 3695
- Hirota, 2002, J Biol Chem, 277, 44244
- Kobayashi, 2003, Kidney Int, 64, 1632
- Schulze, 2004, J Biol Chem, 279, 30369
- Hansen, 2004, Biochem Biophys Res Commun, 323, 685
- Minn, 2005, Endocrinology, 146, 2397
- Wolfrum, 2003, Proc Natl Acad Sci U S A, 100, 11624
- Elbein, 1999, Diabetes, 48, 1175
- Vionnet, 2000, Am J Hum Genet, 67, 1470
- Donnelly, 2004, J Nutr, 134, 1475
- Sheth, 2005, J Lipid Res, 46, 123
- Brownlee, 2001, Nature, 414, 813
- Houstis, 2006, Nature, 440, 944
- Petersen, 2003, Science, 300, 1140
- Wang, 2006, Oncogene, 25, 1903
- Han, 2003, Oncogene, 22, 4035
- DeFronzo, 2004, Med Clin North Am, 88
- Bonner-Weir, 2000, Trends Endocrinol Metab, 11, 375
- Poitout, 2002, Endocrinology, 143, 339
- Zierath, 2003, Best Pract Res Clin Endocrinol Metab, 17, 385
- Barrett, 2005, Bioinformatics, 21, 263
- Furuyama, 2000, Biochem J, 349, 629
Cited by
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
“Moreover, the NLRP3-binding protein, TXNIP, is itself heavily implicated in T2D, as a mediator of pancreatic b cell death and failing peripheral glucose uptake (Parikh et al., 2007; Shalev, 2008).”
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
“In beta cells, TXNIP is downregulated by insulin, and TXNIP expression is consistently higher in humans with type 2 diabete”
BackgroundThe PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism
Hoxhaj, G., & Manning, B. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0216-7 · Cited by 2,137
The thioredoxin antioxidant system
Lu, J., & Holmgren, A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.036 · Cited by 2,055
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990
The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Schroder, K., Zhou, R., & Tschopp, J. (2010) · Science · doi:10.1126/science.1184003 · Cited by 1,134
Tumour acidosis: from the passenger to the driver's seat
Corbet, C., & Feron, O. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.77 · Cited by 988
Lerner, A. G., Upton, J.-P., Praveen, P. V. K., Ghosh, R., Nakagawa, Y., Igbaria, A., Shen, S., Nguyen, V., Backes, B. J., Heiman, M., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.007 · Cited by 846
“TXNIP levels are elevated in the muscle of diabetic humans and mice (Parikh et al., 2007), and TXNIP-deficient mice have increased adiposity while remaining insulin sensitive (Hui et al.”
Hanschmann, E.-M., Godoy, J. R., Berndt, C., Hudemann, C., & Lillig, C. H. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4599 · Cited by 677
AMPK-Dependent Degradation of TXNIP upon Energy Stress Leads to Enhanced Glucose Uptake via GLUT1
Wu, N., Zheng, B., Shaywitz, A., Dagon, Y., Tower, C., Bellinger, G., Shen, C.-H., Wen, J., Asara, J., McGraw, T. E., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.035 · Cited by 665
“Molec thioredoxin-binding property, TXNIP overexpression represses cellular glucose uptake, whereas TXNIP knockdown increases glucose uptake in peripheral tissues in both an insulindependent and an insulin-independent manner (Parikh et al., 2007).”
BackgroundInfluentialContext-Specific Metabolic Networks Are Consistent with Experiments
Becker, S. A., & Palsson, B. O. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000082 · Cited by 592
“GI 6 subjects before glucose/insulin infusion via clamp and 2 hours after beginning (vastus lateralis) [28] GSE7146”
MethodYang, X., Lu, X., Lombès, M., Rha, G. B., Chi, Y.-I., Guerin, T. M., Smart, E. J., & Liu, J. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.02.003 · Cited by 482
“Previous studies have shown that G0S2 mRNA level is upregulated by insulin in skeletal muscle (Parikh et al., 2007), by glucose in liver (Ma et al.”
Thioredoxin and Thioredoxin Target Proteins: From Molecular Mechanisms to Functional Significance
Lee, S., Kim, S. M., & Lee, R. T. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4322 · Cited by 433
“Microarray transcriptional expression profiling showed that TXNIP expression was suppressed by insulin and increased in muscle tissue of patients with diabetes mellitus, consistent with known induction of the TXNIP gene by glucose (228).”
InfluentialSelf-citationInteractions between mitochondrial reactive oxygen species and cellular glucose metabolism
Liemburg-Apers, D. C., Willems, P. H. G. M., Koopman, W. J. H., & Grefte, S. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1520-y · Cited by 391
Mahmoud, A. M., Ashour, M. B., Abdel-Moneim, A., & Ahmed, O. M. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.06.001 · Cited by 374
“The progression of T2DM includes the development of insulin resistance, impaired glucose tolerance and eventual pancreatic β-cell dysfunction (Kahn, Hull, & Utzschneider, 2006; Parikh et al., 2007).”
BackgroundThioredoxin/Txnip: Redoxisome, as a Redox Switch for the Pathogenesis of Diseases
Yoshihara, E., Masaki, S., Matsuo, Y., Chen, Z., Tian, H., & Yodoi, J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00514 · Cited by 362
“Insulin sensitivity (muscle, adipose) No report Suppress (28, 36, 59, 71, 72)”
BackgroundInfluentialTXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target
Choi, E.-H., & Park, S.-J. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01019-8 · Cited by 330
Thioredoxin-Interacting Protein
Chen, J., Saxena, G., Mungrue, I. N., Lusis, A. J., & Shalev, A. (2008) · Diabetes · doi:10.2337/db07-0715 · Cited by 350
“In addition, a recent human study (40) demonC57BL/6”
BackgroundLipid-Induced Mitochondrial Stress and Insulin Action in Muscle
Muoio, D. M., & Neufer, P. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.010 · Cited by 343
“TXNIP not only binds to and inhibits thioredoxin, but also antagonizes glucose uptake through a yet undefined mechanism (Parikh et al., 2007).”
BackgroundGboxin is an oxidative phosphorylation inhibitor that targets glioblastoma
Shi, Y., Lim, S. K., Liang, Q., Iyer, S. V., Wang, H.-Y., Wang, Z., Xie, X., Sun, D., Chen, Y.-J., Tabar, V., et al. (2019) · Nature · doi:10.1038/s41586-019-0993-x · Cited by 325
Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives
Beard, E., Lengacher, S., Dias, S., Magistretti, P. J., & Finsterwald, C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.825816 · Cited by 302
Mitochondria: Sovereign of inflammation?
Tschopp, J. (2011) · European Journal of Immunology · doi:10.1002/eji.201141436 · Cited by 292
Stoltzman, C. A., Peterson, C. W., Breen, K. T., Muoio, D. M., Billin, A. N., & Ayer, D. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712199105 · Cited by 283
“Overexpression of TXNIP in skeletal muscle down-regulates peripheral glucose uptake, which is proposed to lead to elevated circulating glucose levels, especially in cases of energy overload (17, 25).”
BackgroundInfluentialTight Coordination of Protein Translation and HSF1 Activation Supports the Anabolic Malignant State
Santagata, S., Mendillo, M. L., Tang, Y.-C., Subramanian, A., Perley, C. C., Roche, S. P., Wong, B., Narayan, R., Kwon, H., Koeva, M., et al. (2013) · Science · doi:10.1126/science.1238303 · Cited by 285
The Inflammasome Puts Obesity in the Danger Zone
Stienstra, R., Tack, C. J., Kanneganti, T.-D., Joosten, L. A. B., & Netea, M. G. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.011 · Cited by 271
“Interestingly, TXNIP levels are elevated in subjects with type 2 diabetes mellitus (Parikh et al., 2007), and its expression is robustly induced by glucose (Stoltzman et al., 2008).”
BackgroundExposing the exposures responsible for type 2 diabetes and obesity
Franks, P. W., & McCarthy, M. I. (2016) · Science · doi:10.1126/science.aaf5094 · Cited by 265
Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases
Liu, D., Zeng, X., Li, X., Mehta, J. L., & Wang, X. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-017-0663-9 · Cited by 258
Human SGBS Cells – a Unique Tool for Studies of Human Fat Cell Biology
Fischer-Posovszky, P., Newell, F. S., Wabitsch, M., & Tornqvist, H. E. (2008) · Obesity Facts · doi:10.1159/000145784 · Cited by 250
Self-citationAlibegovic, A. C., Sonne, M. P., Højbjerre, L., Bork-Jensen, J., Jacobsen, S., Nilsson, E., Færch, K., Hiscock, N., Mortensen, B., Friedrichsen, M., et al. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00590.2009 · Cited by 247
“Impaired FFA oxidation might result in accumulation of long-chain acyl-CoAs (LC-CoAs), diacylglycerol, ceramides, Table 2. mRNA expression of 26 candidate genes measured by qRT-PCR and normalized to PPIA Gene expression (mRNA) Basal State Insulin Stimulation Insulin Effect Before bed rest (n 20) After bed rest (n 20)…”
BackgroundInfluentialSelf-citationPreventing β-Cell Loss and Diabetes With Calcium Channel Blockers
Xu, G., Chen, J., Jing, G., & Shalev, A. (2012) · Diabetes · doi:10.2337/db11-0955 · Cited by 246
“In addition, while the strongest effects are expected in tissues with high expression levels of L-type calcium channels, such as heart and b-cells, downregulation of TXNIP in other tissues seems also to be beneficial (14,15) and might be responsible for the improved insulin sensitivity we observed in BTBR ob/obmice (F…”
BackgroundPhosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in Response to Insulin
Waldhart, A. N., Dykstra, H., Peck, A. S., Boguslawski, E. A., Madaj, Z. B., Wen, J., Veldkamp, K., Hollowell, M., Zheng, B., Cantley, L. C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.041 · Cited by 242
“TXNIP protein negatively regulates glucose uptake in cells via its role as a GLUT1 adaptor to the clathrin-mediated endocytosis machinery (Parikh et al., 2007; Wu et al., 2013).”
BackgroundGlutamine Metabolism in Cancer
Li, T., & Le, A. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-77736-8_2 · Cited by 235
Metabolic pathways in obesity-related breast cancer
Brown, K. A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00487-0 · Cited by 234
Chen, J., Hui, S. T., Couto, F. M., Mungrue, I. N., Davis, D. B., Attie, A. D., Lusis, A. J., Davis, R. A., & Shalev, A. (2008) · The FASEB Journal · doi:10.1096/fj.08-111690 · Cited by 225
“pression inhibited glucose uptake (35).”
Recent progress in genetic and epigenetic research on type 2 diabetes
Kwak, S. H., & Park, K. S. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.7 · Cited by 223
TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook
Alhawiti, N. M., Al Mahri, S., Aziz, M. A., Malik, S. S., & Mohammad, S. (2017) · Current Drug Targets · doi:10.2174/1389450118666170130145514 · Cited by 223
TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation
Park, H.-S., Song, J.-W., Park, J.-H., Lim, B.-K., Moon, O.-S., Son, H.-Y., Lee, J.-H., Gao, B., Won, Y.-S., & Kwon, H.-J. (2021) · Autophagy · doi:10.1080/15548627.2020.1834711 · Cited by 219
Txnip balances metabolic and growth signaling via PTEN disulfide reduction
Hui, S. T. Y., Andres, A. M., Miller, A. K., Spann, N. J., Potter, D. W., Post, N. M., Chen, A. Z., Sachithanantham, S., Jung, D. Y., Kim, J. K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800293105 · Cited by 214
“These findings are consistent with studies showing that Txnip regulates both the insulin-dependent and insulin-independent pathways of glucose uptake in human skeletal muscle (20).”
ResultMetabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer
Lien, E. C., Lyssiotis, C. A., & Cantley, L. C. (2016) · Recent Results in Cancer Research · doi:10.1007/978-3-319-42118-6_3 · Cited by 212
Thioredoxin-interacting Protein (Txnip) Is a Critical Regulator of Hepatic Glucose Production
Chutkow, W. A., Patwari, P., Yoshioka, J., & Lee, R. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708169200 · Cited by 204
Self-citationEffects of high glucose on mesenchymal stem cell proliferation and differentiation
Li, Y.-M., Schilling, T., Benisch, P., Zeck, S., Meissner-Weigl, J., Schneider, D., Limbert, C., Seufert, J., Kassem, M., Schütze, N., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.161 · Cited by 198
“Employing patch-clamp techniques it was demonstrated that overexpression of Txnip inhibited glucose uptake while its knockdown acted vice versa [13].”
Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy
Qiu, Y.-Y., & Tang, L.-Q. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.004 · Cited by 195
“In beta cells, TXNIP is downregulated by insulin, and TXNIP expression is consistently higher in humans with type 2 diabetes [97].”
BackgroundThioredoxin-independent Regulation of Metabolism by the α-Arrestin Proteins
Patwari, P., Chutkow, W. A., Cummings, K., Verstraeten, V. L. R. M., Lammerding, J., Schreiter, E. R., & Lee, R. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018093 · Cited by 195
Self-citationThioredoxin Interacting Protein: Redox Dependent and Independent Regulatory Mechanisms
Spindel, O. N., World, C., & Berk, B. C. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4137 · Cited by 193
“Further, TXNIP expression correlated inversely with total body measures of glucose uptake (50).”
BackgroundInflammation links excess fat to insulin resistance: the role of the interleukin‐1 family
Tack, C. J., Stienstra, R., Joosten, L. A. B., & Netea, M. G. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01145.x · Cited by 193
“TXNIP is expressed in a wide variety of cell types including skeletal myocytes, pancreatic b-cells, endothelial cells, but also by adipocytes and acts as an endogenous inhibitor of the reactive oxygen species (ROS) scavenging protein thioredoxin (47, 48).”
BackgroundEpstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation
Wang, L. W., Shen, H., Nobre, L., Ersing, I., Paulo, J. A., Trudeau, S., Wang, Z., Smith, N. A., Ma, Y., Reinstadler, B., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.003 · Cited by 190
“Thioredoxin-interacting protein (TXNIP), a potent negative regulator of glucose metabolism (Parikh et al., 2007), was concomitantly and strongly downregulated by EBV (Figure 1E).”
BackgroundSelf-citationSoriano-Tárraga, C., Jiménez-Conde, J., Giralt-Steinhauer, E., Mola-Caminal, M., Vivanco-Hidalgo, R. M., Ois, A., Rodríguez-Campello, A., Cuadrado-Godia, E., Sayols-Baixeras, S., Elosua, R., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddv493 · Cited by 191
“sion is consistently elevated in the muscle of pre-diabetic and diabetic patients (28).”
BackgroundPetersen, A.-K., Zeilinger, S., Kastenmüller, G., Römisch-Margl, W., Brugger, M., Peters, A., Meisinger, C., Strauch, K., Hengstenberg, C., Pagel, P., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt430 · Cited by 183
“However, the authors found no evidence for association between common genetic variation in the TXNIP gene and type 2 diabetes (28).”
BackgroundMinireview: Thioredoxin-Interacting Protein: Regulation and Function in the Pancreatic β-Cell
Shalev, A. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1095 · Cited by 185
The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein
Hwang, J., Suh, H.-W., Jeon, Y. H., Hwang, E., Nguyen, L. T., Yeom, J., Lee, S.-G., Lee, C., Kim, K. J., Kang, B. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms3958 · Cited by 176
Lighting the fires within: the cell biology of autoinflammatory diseases
Park, H., Bourla, A. B., Kastner, D. L., Colbert, R. A., & Siegel, R. M. (2012) · Nature Reviews Immunology · doi:10.1038/nri3261 · Cited by 174
Hyperglycemia Activates Caspase-1 and TXNIP-Mediated IL-1β Transcription in Human Adipose Tissue
Koenen, T. B., Stienstra, R., van Tits, L. J., de Graaf, J., Stalenhoef, A. F. H., Joosten, L. A. B., Tack, C. J., & Netea, M. G. (2011) · Diabetes · doi:10.2337/db10-0266 · Cited by 172
“TXNIP is expressed in a wide variety of cell types including skeletal myocytes, pancreatic b-cells, endothelial cells, and adipocytes and acts as an endogenous inhibitor of the reactive oxygen species (ROS) scavenging protein thioredoxin (14,15).”
BackgroundInfluentialNovel epigenetic determinants of type 2 diabetes in Mexican-American families
Kulkarni, H., Kos, M. Z., Neary, J., Dyer, T. D., Kent, J. W., Göring, H. H. H., Cole, S. A., Comuzzie, A. G., Almasy, L., Mahaney, M. C., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv232 · Cited by 172
Kaadige, M. R., Looper, R. E., Kamalanaadhan, S., & Ayer, D. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901221106 · Cited by 162
“TXNIP is a potent negative regulator of glucose uptake (7, 12, 14), therefore its repression by glutamine suggests a mechanism that coordinates the response to glucose and glutamine.”
BackgroundNasoohi, S., Ismael, S., & Ishrat, T. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0917-z · Cited by 160
“Elevated expression of TXNIP has been observed in the muscle of pre-diabetic and diabetic patients [33].”
BackgroundInfluentialYoshioka, J., Chutkow, W. A., Lee, S., Kim, J. B., Yan, J., Tian, R., Lindsey, M. L., Feener, E. P., Seidman, C. E., Seidman, J. G., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci44927 · Cited by 158
Self-citationRole of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook
Qayyum, N., Haseeb, M., Kim, M. S., & Choi, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052754 · Cited by 160
“Remarkably, NLRP3 and TXNIP knockout mice show improved glucose tolerance and insulin sensitivity in a T2DM model [29].”
BackgroundInfluentialMohamed, I., Hafez, S. S., Fairaq, A., Ergul, A., Imig, J. D., & El‐Remessy, A. B. (2013) · Diabetologia · doi:10.1007/s00125-013-3101-z · Cited by 166
“TXNIP expression, a well-established mediator of insulin resistance, has been shown to be consistently elevated in the muscles of insulin-resistant and diabetic individuals [16, 17].”
Metabolic remodelling in diabetic cardiomyopathy
Chong, C., Clarke, K., & Levelt, E. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx018 · Cited by 183
“In 2002, thioredoxin interacting protein (TXNIP) was reportedly the gene most upregulated by high glucose concentrations in a human islet oligonucleotide gene expression microarray;(52) and one of the most responsive genes to blood glucose levels and insulin signalling in T2D patients.(53) Ubiquitously expressed and p…”
BackgroundShah, A., Xia, L., Goldberg, H., Lee, K. W., Quaggin, S. E., & Fantus, I. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.419101 · Cited by 153
Florath, I., Butterbach, K., Heiss, J. A., Bewerunge‐Hudler, M., Zhang, Y., Schöttker, B., & Brenner, H. (2015) · Diabetologia · doi:10.1007/s00125-015-3773-7 · Cited by 166
“tissue treated with 25 mmol/l glucose [29] and regulates insulin-dependent and insulin-independent pathways of glucose uptake in human skeletal muscle [30].”
BackgroundThioredoxin-Interacting Protein (TXNIP) with Focus on Brain and Neurodegenerative Diseases
Tsubaki, H., Tooyama, I., & Walker, D. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249357 · Cited by 157
“These include UV light, heat shock [51], hypoxia, ROS, nitric oxide [52], nicotinamide adenine dinucleotide [53], ATP, glutamine, nicotine, vascular endothelial growth factor, basic fibroblast growth factor [54], transforming growth factor β [55], estradiol [56], calcium channel blockers [57], activators of advanced g…”
BackgroundEpigenetic associations of type 2 diabetes and BMI in an Arab population
Al‐Muftah, W., Al-Shafai, M. N., Zaghlool, S. B., Visconti, A., Tsai, P.-C., Kumar, P., Spector, T. D., Bell, J. T., Falchi, M., & Suhre, K. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0177-6 · Cited by 158
“A recent study showed that TXNIP is involved in glucose regulation by controlling insulin sensitivity in the periphery of the human body, and its expression is elevated in the skeletal muscles in T2D patients [37] indicating a linkage to phenotype.”
BackgroundChutkow, W. A., Birkenfeld, A. L., Brown, J. D., Lee, H.-Y., Frederick, D. W., Yoshioka, J., Patwari, P., Kursawe, R., Cushman, S. W., Plutzky, J., et al. (2010) · Diabetes · doi:10.2337/db09-1212 · Cited by 142
“Finally, we examined both PPAR and Txnip expression, as PPAR expression is influenced by its own activation (33), and Txnip expression is augmented in states of insulin resistance (16).”
InfluentialSelf-citationCedernaes, J., Schönke, M., Westholm, J. O., Mi, J., Chibalin, A., Voisin, S., Osler, M., Vogel, H., Hörnaeus, K., Dickson, S. L., et al. (2018) · Science Advances · doi:10.1126/sciadv.aar8590 · Cited by 137
Self-citationWatanabe, R., Nakamura, H., Masutani, H., & Yodoi, J. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.004 · Cited by 139
Biochemical regulation of the inflammasome
Dowling, J. K., & O’Neill, L. A. J. (2012) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2012.694844 · Cited by 135
“, 2010), repressed by insulin and elevated in T2D (Parikh et al., 2007) a disease in which an imbalance of IL-1β activity impacts on islet inflammation.”
BackgroundInfluentialLactic Acidosis Triggers Starvation Response with Paradoxical Induction of TXNIP through MondoA
Chen, J. L.-Y., Merl, D., Peterson, C. W., Wu, J., Liu, P. Y., Yin, H., Muoio, D. M., Ayer, D. E., West, M., & Chi, J.-T. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001093 · Cited by 137
“Although TXNIP was initially identified as a protein interacting with thioredoxin and modulating cellular responses to oxidative stresses, it has the ability to inhibit glucose uptake and is being recognized as an important regulator of dysregulated metabolism in diabetes [54,55].”
BackgroundFeuer, S. K., Liu, X., Donjacour, A. A., Lin, W., Simbulan, R. K., Giritharan, G., Piane, L. D., Kolahi, K. S., Ameri, K., Maltepe, E., et al. (2014) · Endocrinology · doi:10.1210/en.2013-2081 · Cited by 136
AMPK-Regulated Astrocytic Lactate Shuttle Plays a Non-Cell-Autonomous Role in Neuronal Survival
Muraleedharan, R., Gawali, M. V., Tiwari, D., Sukumaran, A., Oatman, N., Anderson, J., Nardini, D., Bhuiyan, M. A. N., Tkáč, I., Ward, A. L., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108092 · Cited by 130
“The arrestin superfamily protein TXNIP is an evolutionarily conserved glucose-inducible protein that is involved in human pathology, such as diabetes and diabetic retinopathy (Bodnar et al., 2002; Chutkow et al., 2008; Parikh et al., 2007; Singh, 2013).”
Szpigel, A., Hainault, I., Carlier, A., Venteclef, N., Batto, A.-F., Hajduch, É., Bernard, C., Ktorza, A., Gautier, J., Ferré, P., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4462-5 · Cited by 142
The G0/G1 switch gene 2 (G0S2): Regulating metabolism and beyond
Heckmann, B. L., Zhang, X., Xie, X., & Liu, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.09.016 · Cited by 152
“after a euglycemic hyperinsulinemic clamp [6].”
Muri, J., Heer, S., Matsushita, M., Pohlmeier, L. M., Tortola, L., Fuhrer, T., Conrad, M., Zamboni, N., Kisielow, J., & Köpf, M. (2018) · Nature Communications · doi:10.1038/s41467-018-04274-w · Cited by 145
Glutamine Metabolism in Cancer
Li, T., Copeland, C., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_2 · Cited by 154
Mechanism by Which Caloric Restriction Improves Insulin Sensitivity in Sedentary Obese Adults
Johnson, M. L., Distelmaier, K., Lanza, I. R., Irving, B. A., Robinson, M. M., Konopka, A. R., Shulman, G. I., & Nair, K. S. (2016) · Diabetes · doi:10.2337/db15-0675 · Cited by 129
“Furthermore, insulin-resistant individuals and those with T2D exhibit elevations in TXNIP mRNA (23).”
BackgroundA molecular switch on an arrestin-like protein relays glucose signaling to transporter endocytosis
Becuwe, M., Vieira, N., Lara, D., Gomes-Rezende, J., Soares‐Cunha, C., Casal, M., Haguenauer‐Tsapis, R., Vincent, O., Paiva, S., & Sébastien Léon, A. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201109113 · Cited by 133
“, 2010), is particularly relevant to our paper because both TXNIP and Rod1 regulate glucose transport activity (Parikh et al., 2007; Lin et al., 2008; Nikko and Pelham, 2009).”
Vilardell, M., Rasche, A., Thormann, A., Maschke-Dutz, E., Pérez-Jurado, L. A., Lehrach, H., & Herwig, R. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-229 · Cited by 132
Hexokinase-2 Glycolytic Overload in Diabetes and Ischemia–Reperfusion Injury
Rabbani, N., & Thornalley, P. J. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.04.011 · Cited by 129
Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions
Maulik, N., & Das, D. K. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.12.008 · Cited by 140
Mitochondrial Deficiency Is Associated With Insulin Resistance
Goodpaster, B. H. (2013) · Diabetes · doi:10.2337/db12-1612 · Cited by 124
“This should be viewed in the context of studies demonstrating hexokinase binding to mitochondria (34) and its link to thioredoxin-interacting protein (TXNIP) as well as TXNIP effects to inhibit glucose uptake in humans (35).”
BackgroundExpression, Localization, and Function of the Thioredoxin System in Diabetic Nephropathy
Advani, A., Gilbert, R. E., Thai, K., Gow, R. M., Langham, R. G., Cox, A. J., Connelly, K. A., Zhang, Y., Herzenberg, A. M., Christensen, P. K., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008020142 · Cited by 122
The Arrestin Domain-Containing 3 Protein Regulates Body Mass and Energy Expenditure
Patwari, P., Emilsson, V., Schadt, E. E., Chutkow, W. A., Lee, S., Marsili, A., Zhang, Y., Dobrin, R., Cohen, D. E., Larsen, P. R., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.011 · Cited by 120
“TXNIP, first identified as an inhibitor of thioredoxin, is known to regulate metabolism and insulin responsiveness by inhibiting glucose uptake into muscle and by shifting glucose usage from glycolytic to aerobic pathways (Parikh et al., 2007; Chen et al., 2008; Chutkow et al., 2010).”
BackgroundSelf-citationKadota, K., Nakai, Y., & Shimizu, K. (2008) · Algorithms for Molecular Biology · doi:10.1186/1748-7188-3-8 · Cited by 135
The Emerging Role of the Thioredoxin System in Angiogenesis
Dunn, L. L., Buckle, A. M., Cooke, J. P., & Ng, M. K. C. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.209643 · Cited by 118
Differential control of ATGL-mediated lipid droplet degradation by CGI-58 and G0S2
Lu, X., Yang, X., & Liu, J. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12181 · Cited by 116
TXNIP: A Double‐Edged Sword in Disease and Therapeutic Outlook
Pan, M., Zhang, F., Qu, K., Liu, C., & Zhang, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7805115 · Cited by 122
“TXNIP levels increased signi fi cantly in diabetic patients and those with chronic hyperglycemia, suggesting that TXNIP levels are bound up with the development and progression of diabetes [46].”
Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity
Yoshihara, E., Fujimoto, S., Inagaki, N., Okawa, K., Masaki, S., Yodoi, J., & Masutani, H. (2010) · Nature Communications · doi:10.1038/ncomms1127 · Cited by 118
Yang, X., Zhang, X., Heckmann, B. L., Lu, X., & Liu, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257923 · Cited by 115
Zhang, P., Wang, C., Gao, K., Wang, D., Mao, J., An, J., Xu, C., Wu, D., Yu, H., Liu, J. O., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.063321 · Cited by 128
Hong, S. Y., Yu, F., Luo, Y., & Hagen, T. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.01.011 · Cited by 113
An expanded family of arrestins regulate metabolism
Patwari, P., & Lee, R. T. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.03.003 · Cited by 127
Self-citationSteneberg, P., Lindahl, E., Dahl, U., Lidh, E., Straseviciene, J., Backlund, F., Kjellkvist, E., Berggren, E., Lundberg, I., Bergqvist, I., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99114 · Cited by 108
“…and insulin resistance, O304 and O304+Met-formin, but not Metformin, significantly increased pAMPK (Figure 2E), reduced Txnip mRNA levels, and increased Glut1 mRNA levels (Figure 2F) in calf muscle of DIO mice, which is consistent with both insulin-dependent and insulin-independent effects (39–41).”
BackgroundHe, X., & Ma, Q. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.081133 · Cited by 111
“In diabetes, TXNIP is persistently elevated and is implicated in β -cell apoptosis, peripheral insulin resistance, and defective glucose homeostasis (Parikh et al., 2007).”
InfluentialStressing out the mitochondria: Mechanistic insights into NLRP3 inflammasome activation
Yabal, M., Calleja, D. J., Simpson, D. S., & Lawlor, K. E. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0318-124r · Cited by 109
Zhao, Y., Li, Q., Zhao, W., Li, J., Sun, Y., Liu, K., Liu, B., & Zhang, N. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.04.030 · Cited by 109
Phagosomal removal of fungal melanin reprograms macrophage metabolism to promote antifungal immunity
Gonçalves, S. M., Duarte-Oliveira, C., Campos, C. F., Aimanianda, V., ter Horst, R., Leite, L., Mercier, T., Pereira, P., Fernández-García, M., Antunes, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16120-z · Cited by 108
Elbein, S. C., Kern, P. A., Rasouli, N., Yao-Borengasser, A., Sharma, N. K., & Das, S. K. (2011) · Diabetes · doi:10.2337/db10-1270 · Cited by 107
Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy
Shah, A., Xia, L., Masson, E., Gui, C., Momen, A., Shikatani, E. A., Husain, M., Quaggin, S. E., John, R., & Fantus, I. G. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050528 · Cited by 111
Sayols-Baixeras, S., Subirana, I., Lluís-Ganella, C., Civeira, F., Roquer, J., Do, A., Absher, D., Cenarro, A., Muñoz, D., Soriano‐Tárraga, C., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw285 · Cited by 129
Reciprocal Regulation of Endocytosis and Metabolism
Antonescu, C. N., McGraw, T. E., & Klip, A. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016964 · Cited by 104
“TXNIP expression correlates with glucose transport and its knockdown in adipose and muscle cells lowered glucose uptake (Parikh et al. 2007).”
Background
Metadata
- Authors
- Parikh, H., Carlsson, E., Chutkow, W. A., Johansson, L. E., Storgaard, H., Poulsen, P., Saxena, R., Ladd, C., Schulze, P. C., Mazzini, M. J., Jensen, C. B., Krook, A., Björnholm, M., Tornqvist, H., Zierath, J. R., Ridderstråle, M., Altshuler, D., Lee, R. T., Vaag, A., Groop, L. C., & Mootha, V. K.
- Affiliations
- Lund University (SE)
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Karolinska Institutet (SE)
- Novo Nordisk (Denmark) (DK)
- University of Helsinki (FI)
- Corresponding author
- Groop, Leif C
- Mootha, Vamsi K
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-05-01
- Volume
- 4
- Issue
- 5
- Pages
- e158
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC1858708
- OpenAlex
- W2158951820
- Cited by
- 495
- References
- 57
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 24 · 2023: 41 · 2022: 35 · 2021: 39 · 2020: 34 · 2019: 22 · 2018: 29 · 2017: 21 · 2016: 29 · 2015: 29 · 2014: 23 · 2013: 28 · 2012: 31
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- American Diabetes Association
- Burroughs Wellcome Fund
- Richard and Susan Smith Family Foundation
- European Commission
- Karolinska Institutet
- Novo Nordisk
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- TXNIP, type 2 diabetes, skeletal muscle glucose uptake, peripheral glucose metabolism, insulin signaling, adipocytes, prediabetes, glucose homeostasis, insulin-independent glucose uptake, genetic association
- MeSH terms
- Animals, Blood Glucose, Carrier Proteins, Cells, Cultured, Diabetes Mellitus, Type 2, DNA-Binding Proteins, Gene Expression Regulation, Homeostasis, Humans, Hypoglycemic Agents, Insulin, Promoter Regions, Genetic, Glucose Clamp Technique, Linkage Disequilibrium, Polymerase Chain Reaction, Adipocytes, Glucose Intolerance, Muscle, Skeletal, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Protein Array Analysis, Qb-SNARE Proteins, Proto-Oncogene Proteins c-bcl-6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.